Dr. Michael S. Schwartz, MD

Dr. Schwartz practices at Baylor Scott & White Surgicare - Carrollton (N Josey Ln) in Carrollton, Texas.

Dr. Schwartz's NPI, 1427041557, was assigned on August 24, 2005. Dr. Schwartz graduated from Jacobs School of Medicine and Biomedical Sciences in 1992. Dr. Schwartz holds Texas license K3848.

Dr. Schwartz's primary practice is Baylor Scott & White Surgicare - Carrollton (N Josey Ln), at 4780 N Josey Lane, Carrollton, TX 75010. The practice phone is (972) 395-0440.

Dr. Schwartz's primary practice is Baylor Scott & White Surgicare - Carrollton (N Josey Ln) in Carrollton, Texas. Dr. Schwartz is also affiliated with Baylor Scott & White Institute for Rehabilitation - Dallas. The medical group on file is OrthoTexas. Dmand AI also links Dr. Schwartz to 3 more hospitals, 2 group practices and clinics, 1 home health agency, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Schwartz is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Schwartz's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists arthritis, bursitis, enthesopathy in arms, fluid in a joint, hand joint or tendon inflammation, joint pain, knee arthroscopy and knee fracture and dislocation among the conditions Dr. Schwartz treats.

CMS data shows 3,563 Medicare services from Dr. Schwartz across 15 procedure codes in 2024, for 349 Medicare patients. Medicare paid $152,474 for them.

CMS counts 349 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have arthritis, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 57, with 53% women.

In 2024, Dr. Schwartz wrote 337 Medicare Part D claims for 153 patients. 100% of them were for generic drugs. CMS names the drug for 318 of them, across 8 drugs with 11 or more claims each, at $3,167 in total drug cost. In 2023, CMS named 353 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Schwartz, more than 91% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 215 general payments to Dr. Schwartz from 36 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 60% of the total. Medtronic USA, Inc. paid the most, $435,431. It also lists 21 research payments totaling $116,980 from 2016 to 2025.

Dmand AI lists 1 award for Dr. Schwartz, most recently CMS Stage 1 EHR in 2013.

Dr. Schwartz graduated from Jacobs School of Medicine and Biomedical Sciences in 1992.

Dr. Schwartz is in network with 21 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.